Opaleye Management Inc. Aadi Bioscience, Inc. Transaction History

Opaleye Management Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$11.99 - $14.5 $3.02 Million - $3.65 Million	252,046 New	252,046 $3.23 Million
Q4 2021 Feb 14, 2022	SELL	$19.32 - $29.02 $869,786 - $1.31 Million	-45,020 Closed	0 $0
Q3 2021 Nov 16, 2021	BUY	$25.52 - $41.85 $1.15 Million - $1.88 Million	45,020 New	45,020 $1.32 Million

12.6M

23.8K

Ticker AADI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,016,800
Market Cap $59.5M
Description
Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, ...

Get notified when there are updates to the investment portfolio of Opaleye Management Inc., based on Form 13F filings with the SEC.

Stay updated on Opaleye Management Inc. with notifications on news.